Records containing: Male Breast Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-11-28Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens
-
CLINICAL_TRIALS study record update · 2017-09-29A Phase I/II Study of Romidepsin in Combination With Abraxane in Patients With Metastatic Inflammatory Breast Cancer
-
CLINICAL_TRIALS study record update · 2017-08-10Phase I Study of ABT-888 in Combination With Cisplatin and Vinorelbine for Patients With Advanced Triple Negative Breast Cancer and/or BRCA-Mutation Associated Breast Cancer
-
CLINICAL_TRIALS study record update · 2017-08-07Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience
-
CLINICAL_TRIALS study record update · 2017-08-04Phase I-II Study of Denileukin Diftitox (ONTAK®) in Patients With Advanced Refractory Breast Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-07-26Phase I - II Study of Doxil® In Combination With Daily Oral Cyclophosphamide and Herceptin for Patients With HER-2/Neu Positive Disease In Patients With Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2017-07-11Efficacy of Palonosetron in the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Following Dose Dense Adriamycin-Cyclophosphamide Chemotherapy in Early Stage Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2017-06-28Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases
-
CLINICAL_TRIALS study record update · 2017-06-15Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
-
CLINICAL_TRIALS study record update · 2017-06-14Quantitative Dynamic PET and MRI and Breast Cancer Therapy
-
CLINICAL_TRIALS study record update · 2017-05-25Phase I/II Study of Adoptive T Cell Therapy Following In Vivo Priming With a HER-2/Neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine in Patients With Advanced Stage HER2 Overexpressing Breast Cancer
-
CLINICAL_TRIALS study record update · 2017-05-17A Phase II Trial for Patients With Inflammatory (Stage IIIB) and Responsive Metastatic Stage IV Breast Cancer Using Busulfan, Melphalan and Thiotepa Followed by Autologous or Syngeneic PBSC Rescue and 12 Weeks of Post-Engraftment Immunotherapy With Low-Dose IL-2 and GM-CSF
-
CLINICAL_TRIALS study record update · 2017-05-10A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Maleate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer
-
CLINICAL_TRIALS study record update · 2017-04-11A Phase II Study of RO4929097 (IND 109291) in Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Carcinoma
-
CLINICAL_TRIALS study record update · 2017-04-11Phase II Study to Evaluate the Development of HER2/Neu (HER2)-Specific Memory T Cells After HER2 Peptide-based Vaccination in Patients With Advanced Stage Her2+ Breast Cancer
-
CLINICAL_TRIALS study record update · 2017-01-19Phase II Study to Investigate Concurrent Lapatinib and Radiotherapy in Locally Advanced or Locally Recurrent Breast Cancer and the Impact on Breast Cancer Stem Cells
-
CLINICAL_TRIALS study record update · 2016-06-13Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2016-04-21A Phase I Trial of Weekly Paclitaxel in Combination With Bavituximab in Patients With Her-2 Negative Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2015-11-05Phase I/II Study of a Combination of Suberoylanilide Hydroxamic Acid (Vorinostat) Plus Paclitaxel and Bevacizumab in Patients With Advanced Metastatic and/or Local Chest Wall Recurrent Breast Cancer
-
CLINICAL_TRIALS study record update · 2015-05-22A Phase I-II Study of R115777 (Tipifarnib, Zarnestra®) Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients With Stage IIB-IIIC Breast Cancer
-
CLINICAL_TRIALS study record update · 2015-03-19Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) (NSC 701852) as Salvage Therapy in Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2015-03-05A Phase 1/2 Study of Ad.p53 DC Vaccine in Combination With 1-methyl-D-tryptophan in Metastatic Solid Tumors and Invasive Breast Cancer
-
CLINICAL_TRIALS study record update · 2014-11-07A Phase 1 Study of RO4929097 (NSC749225) in Combination With Capecitabine in Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-11-07A Pilot Study of Vorinostat to Restore Sensitivity to Aromatase Inhibitor Therapy
-
CLINICAL_TRIALS study record update · 2014-11-06A Pilot Study of Vorinostat to Restore Sensitivity to Aromatase Inhibitor Therapy Part B